Navigation Links
New Pharmaxis Board Appointment
Date:6/23/2008

SYDNEY, Australia, June 23 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of senior Australian pharmaceutical executive Will Delaat to its board of directors.

Mr Delaat has 35 years experience in the global pharmaceutical industry, most recently as the managing director of the Australian subsidiary of Merck & Co., a position he held from 1997 until his recent retirement.

During his career Mr Delaat has held executive positions in both Europe and Australia for Merck and AstraZeneca. Mr Delaat is experienced in sales and marketing and has been responsible for international product launches and commercialisation of respiratory products.

Mr Delaat also serves the pharmaceutical industry in important representative roles. He is chairman of the Australian pharmaceutical industry's peak body, Medicines Australia, and is chairman of the Pharmaceuticals Industry Council.

''Will Delaat is one of Australia's pharmaceutical industry leaders'' said Pharmaxis Chairman, Denis Hanley. ''The Pharmaxis board will benefit from his invaluable skills and experience.''

In accepting the board director position Mr Delaat said: ''Pharmaxis holds enormous promise and I look forward to being part of its effort to bring innovative medicines to patients world-wide."

For information on all Pharmaxis Board members, go to http://tinyurl.com/3s4g2n .

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements incl
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmaxis Aridol Authorised for Sale in Germany
2. Pharmaxis First Steps into China
3. Pharmaxis to Apply to Market Bronchitol in Australia
4. Pharmaxis Investor Conference Call
5. Pharmaxis Aridol Gains First Asian Approval
6. Pharmaxis Appoints Portuguese Distributor for Aridol
7. Pharmaxis Closes Share Purchase Plan
8. Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
9. Phase III Trial Finds Pharmaxis Bronchitol Effective
10. Corgenix Expands Scientific Advisory Board
11. Spring Point Project Names New Members to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 The prestigious ... of Congress was recently awarded to Juliana Hillis and ... MA, for their project, “From an Egg, Everything: America’s ... 3,000 final entries for the National History Day program ... 300 historians and educators in Washington, D.C. , The ...
(Date:7/28/2014)... developed by researchers at the University of Cambridge, could ... realm of science fiction, such as invisibility cloaks and ... a reality for quite some time, the technique which ... a few billionths of a metre across can be ... them, and works on large chunks all at once. ...
(Date:7/28/2014)... July 28, 2014 Proove Biosciences ... will be exhibiting data and research conducted through their ... Spine Intervention Society’s (ISIS) 22nd Annual Scientific Meeting. ... the Hyatt Regency, in Orlando, Florida. , ... clinical competence of physicians who care for patients suffering ...
(Date:7/28/2014)... PA & Boston, MA (PRWEB) July 28, 2014 ... collaboration agreements with two researchers to further develop potential ... deadly malignant brain tumor, in combination with their patented ... by ITI and Duke University, are based on the ... Chief, Division of Neurosurgery at The Preston Robert Tisch ...
Breaking Biology Technology:In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Building 'invisible' materials with light 2Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4
... at the helm of several companies, Michael Flavin, CEO of ... Ill. across from Argonne National Laboratory ), sees a ... , ,Following a six-month preparation period, Flavin says hell ... financial adviser Legg Mason to raise about $30 ...
... - Automating Peripherals Inc announced that the company's ... standards mandated by the Health Insurance Portability and ... on Accreditation of Healthcare Organizations (JCAHO). SecurALL is ... regulate and monitor facility access throughout an organization ...
... Pilots of F-18s have been using the technology for years ... Soon, automobile drivers will get a similar view with speed, ... their windshield. The goal of the heads-up display is to ... , ,"For many of the distractions that can lead to ...
Cached Biology Technology:Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4
(Date:7/28/2014)... tool that can help advance the genetic engineering ... bioenergy, has been developed by researchers with the ... (JBEI), a multi-institutional partnership led by Lawrence Berkeley ... developed an assay that enables scientists to identify ... critical components in the biosynthesis of plant cell ...
(Date:7/28/2014)... to prevent and treat HIV infection has been problematic ... molecules can arouse as they get rid of the ... Weizmann Institute and the National Institutes of Health (NIH) ... interferons around the time of infection could ... Their research appeared in Nature . , ...
(Date:7/28/2014)... at Harvard University today announced that its human ... formed private company to accelerate development of pharmaceutical, ... The announcement follows a worldwide license agreement between ... start-up Emulate Inc., relating to the use of ... "This is a big win towards achieving our ...
Breaking Biology News(10 mins):How sweet it is 2How sweet it is 3Interfering with interferon 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3
... IOF Medal of Achievement was awarded today at the ... A. Kanis. The award honours an individual ... through original and outstanding scientific work. It underlines an ... and awareness of osteoporosis and to promote medical innovation, ...
... of the Walter and Eliza Hall Institute from 1996-2009 ... the institute,s Molecular Genetics of Cancer division. The ... Doug Hilton, said he was delighted Professor Cory had ... are immensely proud of this latest of Suzanne,s achievements," ...
... -- With thousands of scientists across the globe searching for ... a growing emphasis on finding the "master regulators" that guide ... and the University of Cambridge suggests that a closely connected ... cells (HSCs), the self-renewing cells the body uses to make ...
Cached Biology News:Suzanne Cory becomes first-elected woman president of AAS 2Stem cells: In search of a master controller 2
Sf21 Insect Cells (Frozen) in Max-XP Medium...
... system, 220-240 V, uses floating pin printing ... lipids, and other biomolecules onto a variety ... can generate high-density arrays with greater than ... than 57,000 spots per membrane with a ...
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
... Storage: The kit is stable for 12 months ... contents of the kit cold. , ,Principle: ... silica-gel based membrane which selectively adsorbs up to ... specialized binding buffers. Nucleotides, oligos ( , ,Application: ...
Biology Products: